BioWednesday Stevenage: “Road to Success - Navigating the Innovation Pipeline in Therapeutics"

****Registration for this event is now closed, to enquire about booking please email laurabacchus@onenucleus.com****

We are delighted to be organising this BioWednesday event in collaboration with Stevenage Bioscience Catalyst.

Context:

We are delighted to be hosting this event in collaboration with Stevenage Bioscience Catalyst, home to world leading cell and gene therapy companies.

The focus for the event is to explore the latest advancements in therapeutics and discuss the regulatory and practical challenges and opportunities along the innovation pipeline.

…and there will be pizza!

Programme:

12:30 - Registration and pizza lunch

13.00 - SBC companies showcase 
Autolus (Claudia Mayer, VP and Head of Nucleus Site Delivery and Cell Manufacturing)
Laverock Therapeutics (David Venables, CEO)
Neobe Therapeutics (Pedro Correa de Sampaio, CEO)
NeRRe Therapeutics (Mary Kerr, CEO)
NRG Therapeutics (Neil Miller, CEO)

14.00 – Break

14.30 - Panel Discussion “Road to Success - Navigating the Innovation Pipeline in Therapeutics"
Speakers:
Marco Delise, Entrepreneurship & Business Development Director at Stevenage Bioscience Catalyst (Moderator)
Mai Yee Mishir, Senior Director of Global Regulatory Affairs at Advanced Clinical
Charles Large, CEO at Autifony
James Moon, Professor of Cardiology at UCL, CMR lead at Barts Heart Centre and CEO at Mycardium AI

15.30 - Networking and drinks

17.00 - Close

Prices
Members: Free
Non-members: £50 +VAT
Academics: please contact jasmin@onenucleus.com